Publication - Publication

Guidelines for services providing injecting equipment: Best practice recommendations for commissioners and injecting equipment provision (IEP) services in Scotland

Published: 20 May 2010
Part of:
Health and social care

National guidelines for services providing injecting equipment.

69 page PDF

0 B

69 page PDF

0 B

Guidelines for services providing injecting equipment: Best practice recommendations for commissioners and injecting equipment provision (IEP) services in Scotland

69 page PDF

0 B


1. Scottish Government (2008) Hepatitis C Action Plan for Scotland Phase II: May 2008 - March 2011. Available from: .

2. Scottish Government (2008) The road to recovery. A new approach to tackling Scotland's drug problem. Available at: .

3. Hay G, Gannon M, Casey J, McKeganey N (2009) Estimating the national and local prevalence of problem drug misuse in Scotland. Executive report. Centre for Drug Misuse Research, University of Glasgow. Available at: .

4. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, and the CRDHB (2008). Shooting Up: Infections among injecting drug users in the United Kingdom 2007. London: Health Protection Agency. Available at: .

5. Roy KM, Hutchinson SJ, Wadd S, Taylor A, Cameron SO, Burns S, Molyneaux P, McIntyre PG & Goldberg DJ (2007) Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them. Epidemiology and Infection, 135(3): 433-442.

6. Jones L, Pickering L, Sumnall H, McVeigh J & Bellis MA (2008) A review of the effectiveness and cost-effectiveness of needle and syringe programmes for injecting drug users. Final full report - revised Oct 2008. Available at: .

7. Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T & Goldberg D (2008) Evidence for the effectiveness of harm reduction interventions in preventing Hepatitis C transmission among injecting drug users: a review of reviews. Health Protection Scotland.

8. World Health Organisation (2004) Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Available at: .

9. Loxley W, Toumbourou J, Stockwell T, Haines B, Scott K, Godfrey C, Waters E, Patton G, Fordham R, Gray D, Marshall J, Ryder D, Saggers S, Sand L & Williams J (2004) The prevention of substance use, risk and harm in Australia: a review of the evidence. National Drug Research Institute, Commonwealth Department of Health and Ageing, Government of Australia. Available from (See Chapter 14: Harm Reduction).

10. Commonwealth Department of Health and Ageing (2002). Return on investment in needle and syringe programs in Australia: Summary report. Commonwealth of Australia. Available from .

11. Vickerman P, Hickman M and Judd A (2007) Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study. International Journal of Epidemiology, 36: 396-405.

12. Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart M, Strathdee SA, Currie SL, Schechter MT, O'Shaughnessy MV (2001) Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Canadian Medical Association Journal, 65(7): 889-895.

13. Health Protection Scotland and the University of the West of Scotland (2008). The Needle Exchange Surveillance Initiative ( NESI): Prevalence of HCV, HIV and injecting risk behaviours among injecting drug users attending needle exchanges in Scotland, 2007. Glasgow: Health Protection Scotland. Available at: .

14. Information Services Division Scotland (2008). Drug Misuse Statistics Scotland 2008. Tables A1.29 and A1.31. Available from

15. Information Services Division Scotland (2006). Drug Misuse Statistics Scotland 2006. Tables A1.34 and A1.37. Available from:

16. Rhodes T, Davis M, Judd A (2004) Hepatitis C and its risk management among injectors in London: Renewing harm reduction in the context of uncertainty. Addiction, 99: 621-633.

17. Taylor A, Fleming A, Rutherford J & Goldberg D (2004) Examining the injecting practices of injecting drug users in Scotland. Scottish Executive Effective Interventions Unit. Available from:

18. Scott J (2008) Safety, risks and outcomes from the use of injecting paraphernalia. Scottish Government. Available from:

19. Griesbach D, Abdulrahim D, Gordon D & Dowell K (2006) Needle exchange provision in Scotland. A report of the National Needle Exchange Survey. Scottish Executive. Available at:

20. Tempalski B, Cooper HL, Friedman SR, Des Jarlais DC, Brady J, Gostnell K (2008) Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. International Journal of Drug Policy, 19 Suppl 1:S47-58.

21. Heller DI, Paone D, Siegler A & Karpati A (2009) The syringe gap: An assessment of sterile syringe need and acquisition among syringe exchange program participants in New York City. Harm Reduction Journal, 6:1. January.

22. Several reviews undertaken as part of the process of developing needle exchange guidelines for England are available from NICE at:

23. Dolan K, MacDonald M, Silins E & Topp L (2005) Needle and syringe programs: A review of the evidence. Canberra: Australian Government Department of Health and Ageing. Available at:

24. Queensland Needle and Syringe Program (2007) Queensland needle and syringe program policy. Revised 2007. Available at:

25. Victorian Department of Human Services (2001) Victorian needle and syringe program. Operating policy and guidelines. Health Protection Services Unit, Public Health. Available at:

26. Strike C, Leonard L, Millson M, Anstice S, Berkeley N, Medd E (2006) Ontario needle exchange programs: Best practice recommendations. Available at:

27. British Columbia Centre for Disease Control (2004) Harm reduction supply services policy and guidelines. Available at:

28. Welsh Assembly Government (2005) IEP service framework. Available at:

29. Health Protection Scotland (2007) Scotland's action plan for Hepatitis C Phase I, September 2006 - August 2008: First year progress report. Available from

30. Garden J, Roberts K, Taylor A & Robinson D (2003) Evaluation of the provision of single use citric acid sachets to injecting drug users. Scottish Executive Effective Interventions Unit. Available from:

31. Taylor A, Allen E, Hutchinson S, Roy K, Goldberg D, Ahmed S & Roberts K (2005) An evaluation of the Lord Advocate's Guidance on needle exchange. Scottish Executive Drug Misuse Research Programme. Available from:

32. Cattan M, Bagnall A-M, Akhionbare K & Burrell K (2008) Injecting equipment schemes for injecting drug users. Qualitative evidence review. Final full report - revised Aug 2008. Available at:

33. Matheson C, Bond CM, Mollison J (1999) Attitudinal factors associated with community pharmacists' involvement in services for drug misusers. Addiction, 94(9): 1349-59.

34. Matheson C, Bond CM & Tinelli M (2007) Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade. Journal of Public Health Medicine, 29: 350-357.

35. Hall S & Matheson C (2008) Barriers to the provision of needle-exchange services: A qualitative study in community pharmacies. International journal of pharmacy practice, 16: 11-16.

36. Gowing LR, Proudfoot H, Henry-Edwards SM, Teesson M (2001) Evidence Supporting Treatment. The Effectiveness of Interventions for Illicit Drug Use. Woden: Australian National Council on Drugs.

37. Coyle SL, Needle RH, Normand J (1998) Outreach-based HIV prevention for injecting drug users: A review of published outcome data. Public Health Reports, 113(Supplement 1):19-30.

38. Islam MM & Conigrave KM (2007) Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of IDUs: A review. Harm reduction journal, 4(14).

39. National Institute on Drug Abuse (2000) A Manual to Conduct Community-based Outreach. A manual to reduce the risk of HIV and other blood-borne infections in drug users. Available at:

40. Forth Valley Substance Action Team (2004) Central Scotland Police needle replacement scheme for prisoners, Falkirk Police Station. In Substance, vol. 1(1), p. 2. Available at:

41. Information Services Division Scotland (2008). Drug Misuse Statistics Scotland 2008. Table C3.1. Available from

42. Scottish Prison Service (2008) Prisoner Survey 2008. Eleventh survey bulletin. Available at:

43. Heller-Murphy S (2005) The direction of harm reduction in the SPS: From chaotic drug use to abstinence. Scottish Prison Service. Available at:

44. Lorvick J, Bluthenthal RN, Scott, A, Gilbert ML, Riehman KS, Anderson RL, Flynn NM & Kral AH (2006) Secondary syringe exchange among users of 23 California syringe exchange programs. Substance Use & Misuse, 41: 865-882.

45. Carruthers S (2007) The organization of a community: Community-based prevention of prevention of injecting drug use-related health problems. Substance use & misuse, 42(12-13): 1971-1977.

46. Australia Injecting and Illicit Drug Users' League (2006) A framework for peer education by drug-user organisations. Canberra. Available at:

47. Latkin CA (1998) Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks. Public Health Reports, 113 Suppl 1: 151-159.

48. Griesbach D and Taylor A (2009) Educational interventions to prevent hepatitis C: A review of the literature and expert opinion, NHS Health Scotland. Available at:

49. Broadhead RS, Heckathorn DD, Weakliem DL, Anthony DL, Madray H, Mills RJ & Hughes J (1998). Harnessing peer networks as an instrument for AIDs prevention: results from a peer-driven intervention. Public Health Reports, 113 Suppl 1: 42-57.

50. Elford J, Sherr L, Bolding G, Serie F & Maguire M (2002) Peer-led HIV prevention among gay men in London: process evaluation. AIDS Care, 14(3): 351-60.

51. Islam M, Wodak A & Conigrave KM (2008) The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. International Journal of Drug Policy, 19(6): 436-41.

52. McDonald D (2008) The evaluation of a trial of syringe vending machines in Canberra, Australia. International Journal of Drug Policy, September 12.

53. Tudor M & Gordon D (2008) Interim research into the efficacy of an out-of-hours needle exchange vending machine at The Bridge, Southampton. Presentation at the 2008 National Conference on Injecting Drug Use. Available at:

54. Department for Environment, Food and Rural Affairs (DEFRA) (2005). Tackling drug-related litter. Guidance and good practice. At:

55. Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M (2006) Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infectious Diseases, 8(6): 93.

56. Jeal N & Salisbury C (2004) Self-reported experiences of health services among female street-based prostitutes: a cross-sectional survey. British Journal of General Practice, 54(504): 515-519.

57. Gore SM, Bird AG, Cameron SO, Hutchinson SJ, Burns SM, Goldberg DJ (1999) Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours. QJM: An international journal of medicine, 92(1): 25-32.

58. Matheson C, Anthony GB, Bond C, Rossi MK (2008) Assessing and prioritising the preferences of injecting drug users in needle and syringe exchange service development. Journal of Public Health, 30(2): 133-138.

59. Scottish Executive (2002) Needle and syringe exchange schemes. NHS Health Department Letter (HDL) (2002) 90. Available at:

60. National Needle Exchange Forum, UK Harm Reduction Alliance & Exchange Supplies (2006) Reducing injecting related harm: Consensus statement on best practice. Available from:

61. Crofts N, Caruana S, Bowden S & Kerger M (2000) Minimising harm from hepatitis C virus needs better strategies. BMJ, 321: 899. (October 7).

62. De P, Roy E, Boivin JF, Cox J, Morissette C (2008) Risk of HCV transmission through drug preparation equipment: a systematic and methodological review. Journal of viral hepatitis, 15(4): 279-292.

63. LE Thorpe, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein RS (2002) Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American journal of epidemiology, 155(7): 645-653.

64. H Hagan, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER (2001) Sharing of drug preparation equipment as a risk factor for hepatitis C. American journal of public health, 91(1): 42-46.

65. Jenny Scott, Winfield A, Kennedy E, Bond C (2000) Laboratory study of the effects of citric acid and ascorbic acid on injections prepared with brown heroin. International journal of drug policy, 11(6): 417-422.

66. Personal communication, Glasgow Drugs Crisis Centre.

67. The Misuse of Drugs (Amendment) (No.2) Regulation 2003 (Statutory Instrument No. 2003, No. 1653). See regulation 6A. Available at:

68. The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2005 (Statutory Instrument No. 2005, No. 1507). See part 3. Available at:

69. Scottish Executive (2006) National quality standards for substance misuse services. Available at:

70. Neale J, Sheard L & Tompkins CN (2007) Factors that help injecting drug users to access and benefit from services: A qualitative study. Substance abuse treatment, prevention and policy, 2: 31.

71. Rhodes T, Briggs D, Holloway G, Jones S & Kimber J (2006) Visual assessments of injecting drug use. Research briefing 13. National Treatment Agency for Substance Misuse, London. Available at:

72. Latka M, Hagan H, Kapadia F, Golub ET, Bonner S, Campbell JV, Coady MH, Garfein RS, Pu M, Thomas DL, Thiel TK, Strathdee SA (2008) A randomised intervention trial to reduce the lending of used injection equipment among injection drug users infected with Hepatitis C. American Journal of Public Health, 98(5): 853-861.

73. Neale J, Tompkins C & Sheard L (2008) Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. Health and Social Care in the Community, 16(2):147-54.

74. Effective Interventions Unit (2002) Integrated care for drug users. Principles and practice. Scottish Executive. Available at:

75. Hutchinson SJ, Bird SM & Goldberg DJ (2005) Modeling the current and future disease burden of Hepatitis C among injection drug users in Scotland. Hepatology, 42: 711-723.

76. Royal College of General Practitioners (2007) Guidance for the prevention, testing, treatment and management of hepatitis C in primary care. At:

77. Cullen BL, Hutchinson SJ, Roy KM, Schofield J, Hawkins G, McDonald S, Weir A, McLeod A, Goldberg D (2008) Needs assessment of Hepatitis C testing, treatment, care and support services in Scotland: Overview report. Glasgow: Health Protection Scotland. Available from:

78. Scottish Intercollegiate Guidelines Network ( SIGN) (2006) Management of hepatitis C. SIGN Guideline 92. Available at:

79. Department of Health (2006) Immunisation against infectious diseases (The Green Book). Available at: See Chapter 18 (Hepatitis B).

80. Dolan K et al (2005) Needle and syringe programs: A review of the evidence. Citing Libois A, Fumero E, Castro P, Nomdedeu M, Cruceta A, Gatell J-M and Garcia F (2005) Transmission of hepatitis C virus by discarded-needle injury. Clinical Infectious Diseases Journal 41: 129-130.

81. Personal communication, Health Protection Scotland.

82. See Control of Substances Hazardous to Health ( COSHH) Regulations 2002. Available at: